Search
for
Sort by
Research 31–60 of 1000+
- Studi Molecular Docking Aktivitas Anti Alopecia pada Senyawa yang Terkandung dalam Daun Dadap Serep (Erythrina subumbrans (Hassk.) Merrill)
- Clinical evidence for JAK inhibition in alopecia areata: A comprehensive review
- Oral tofacitinib: a promising treatment in atopic dermatitis, alopecia areata and vitiligo
- The Changing Landscape of Alopecia Areata: The Therapeutic Paradigm
- Safety of Janus Kinase inhibitors in Patients with Alopecia Areata: A Systematic Review
- Advances in the mechanism and new therapies of alopecia areata
- Janus kinase (JAK) inhibitors for the treatment of skin and hair disorders: a review of literature
- A novel therapeutic paradigm for patients with extensive alopecia areata
- Clinical Outcomes for Uptitration of Baricitinib Therapy in Patients With Severe Alopecia Areata
- Effectiveness of Baricitinib on Nail Alopecia Areata: A 48-Week Single-Center Retrospective Study
- Treatment of severe alopecia areata with baricitinib
- Case Report: Reversal of Long-Standing Refractory Diffuse Non-Scarring Alopecia Due to Systemic Lupus Erythematosus Following Treatment With Tofacitinib
- Rapid skin repigmentation on oral ruxolitinib in a patient with coexistent vitiligo and alopecia areata (AA)
- Tofacitinib (Selective Janus Kinase Inhibitor 1 and 3): A promising therapy for the treatment of alopecia areata: A case report of six patients
- Current Treatments for Alopecia Areata
- Single‐cell transcriptomics reveals a senescence‐associated IL ‐6/ CCR6 axis driving radiodermatitis
- JAK-STAT1 as therapeutic target for EGFR deficiency-associated inflammation and scarring alopecia
- Emerging role of baricitinib in dermatology practice: All we need to know!
- Alopecia Areata
- Dissecting Cellulitis of the Scalp: Linking Pathogenesis to Therapy
- Markers of inflammation, metabolic disorders, and principles of treatment for alopecia areata in children
- Novel investigational drugs for alopecia areata and future perspectives
- Precision Dermatology: A Review of Molecular Biomarkers and Personalized Therapies
- 59 Scarring alopecia is driven by the collapse of EGFR-protected JAK-STAT1-sensitive stem cell immune privilege
- Topical metformin as a novel therapy for alopecia areata due to its immunologic effects
- Survey of pediatric dermatologist views on treatment for alopecia areata
- Markers of Venous Thromboembolism Risk in Patients with Alopecia Areata: Is There Anything to Worry about?
- Medical Therapies
- Perceived Efficacy and Risks of Janus Kinase Inhibitors in Pediatric and Young Adult Alopecia Areata: A Cross‐Sectional Survey
- BH14 Irish dermatologists’ experience with Janus kinase inhibitors in alopecia areata